Related Experiment Videos
5-HT1 receptors
Laurence Lanfumey1, Michel Hamon
1INSERM U 288, Faculté de Médecine Pitié-Salpêtrière, 91, Boulevard de l'Hôpital, 75013 Paris, France. lanfumey@ext.jussieu.fr
Current Drug Targets. CNS and Neurological Disorders
|February 18, 2004
Summary
Serotonin 5-HT(1) receptors are key G-protein-coupled receptors involved in various physiological processes. Research highlights their role in migraine treatment and potential for treating anxiety, depression, and dementia.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- The serotonin 5-HT(1) receptor class comprises five subtypes (5-HT(1A), 5-HT(1B), 5-HT(1D), 5-HT(1E), 5-HT(1F)).
- These receptors are G-protein-coupled, featuring a characteristic seven-transmembrane domain structure.
- They interact with G alpha i/G alpha o proteins, inhibiting adenylyl cyclase and modulating ion channels.
Purpose of the Study:
- To review the molecular characteristics, physiological roles, and therapeutic implications of serotonin 5-HT(1) receptors.
- To explore the involvement of 5-HT(1) receptors in neurological and psychiatric conditions.
Main Methods:
- Gene cloning and sequencing of 5-HT(1) receptors in humans and rodents.
- Pharmacological studies using selective agonists and antagonists.
- Phenotypical characterization of knock-out mouse models.
Main Results:
- Mapping of 5-HT(1) receptor distribution in the central nervous system and other tissues.
- Development of triptans, effective antimigraine drugs targeting 5-HT(1B), 5-HT(1D), and 5-HT(1F) receptors.
- Evidence linking 5-HT(1) receptors to anxiety, depression, and cognitive functions.
Conclusions:
- Serotonin 5-HT(1) receptors are crucial drug targets for conditions like migraine.
- Further research into these receptors may lead to novel therapeutics for psychiatric and neurodegenerative disorders.